131 related articles for article (PubMed ID: 12499776)
1. The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
Noda K; Miyoshi E; Kitada T; Nakahara S; Gao CX; Honke K; Shiratori Y; Moriwaki H; Sasaki Y; Kasahara A; Hori M; Hayashi N; Taniguchi N
Tumour Biol; 2002; 23(4):202-11. PubMed ID: 12499776
[TBL] [Abstract][Full Text] [Related]
2. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
[TBL] [Abstract][Full Text] [Related]
3. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
[TBL] [Abstract][Full Text] [Related]
4. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
5. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Noda K; Miyoshi E; Uozumi N; Yanagidani S; Ikeda Y; Gao C; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Hayashi N; Hori M; Taniguchi N
Hepatology; 1998 Oct; 28(4):944-52. PubMed ID: 9755230
[TBL] [Abstract][Full Text] [Related]
7. Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.
Nakagawa T; Moriwaki K; Terao N; Nakagawa T; Miyamoto Y; Kamada Y; Miyoshi E
J Proteome Res; 2012 May; 11(5):2798-806. PubMed ID: 22483194
[TBL] [Abstract][Full Text] [Related]
8. Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines.
Yasuda I; Shiratori Y; Adachi S; Obora A; Takemura M; Okuno M; Shidoji Y; Seishima M; Muto Y; Moriwaki H
J Hepatol; 2002 May; 36(5):660-71. PubMed ID: 11983450
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of alpha-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5).
Fukutomi Y; Omori M; Muto Y; Ninomiya M; Okuno M; Moriwaki H
Jpn J Cancer Res; 1990 Dec; 81(12):1281-5. PubMed ID: 1703522
[TBL] [Abstract][Full Text] [Related]
10. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
[TBL] [Abstract][Full Text] [Related]
11. A lectin-based monoclonal enzyme immunoassay to distinguish fucosylated and non-fucosylated alpha-fetoprotein molecular variants.
Suzuki Y; Aoyagi Y; Muramatsu M; Igarashi K; Saito A; Oguro M; Isemura M; Asakura H
Ann Clin Biochem; 1990 Mar; 27 ( Pt 2)():121-8. PubMed ID: 1691608
[TBL] [Abstract][Full Text] [Related]
12. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
[TBL] [Abstract][Full Text] [Related]
14. The alpha1-6-fucosyltransferase gene and its biological significance.
Miyoshi E; Noda K; Yamaguchi Y; Inoue S; Ikeda Y; Wang W; Ko JH; Uozumi N; Li W; Taniguchi N
Biochim Biophys Acta; 1999 Dec; 1473(1):9-20. PubMed ID: 10580126
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a fucosylated α-fetoprotein-specific monoclonal antibody: a potential application for clinical research.
Egashira Y; Suganuma M; Kataoka Y; Higa Y; Ide N; Morishita K; Kamada Y; Gu J; Fukagawa K; Miyoshi E
Sci Rep; 2019 Aug; 9(1):12359. PubMed ID: 31451706
[TBL] [Abstract][Full Text] [Related]
16. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells.
Li M; Li H; Li C; Zhou S; Guo L; Liu H; Jiang W; Liu X; Li P; McNutt MA; Li G
Int J Cancer; 2009 Jun; 124(12):2845-54. PubMed ID: 19267404
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of revisited fucosylated alpha-fetoprotein (AFP-L3) with an autoanalyzer μTAS in a clinical laboratory.
Choi J; Park Y; Kim JH; Kim HS
Clin Chim Acta; 2012 Jan; 413(1-2):170-4. PubMed ID: 21946051
[TBL] [Abstract][Full Text] [Related]
18. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Nakagawa T; Miyoshi E; Yakushijin T; Hiramatsu N; Igura T; Hayashi N; Taniguchi N; Kondo A
J Proteome Res; 2008 Jun; 7(6):2222-33. PubMed ID: 18479159
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Takayama H; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jul; 26(7):1195-200. PubMed ID: 21410750
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
